Your session is about to expire
← Back to Search
Behavioural Intervention
Transit Passes for People with HIV
N/A
Waitlist Available
Led By Jay Orne, PhD
Research Sponsored by The Aliveness Project
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Inability to communicate in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if giving people living with HIV and unstable housing an unlimited transit pass will help improve their health. Researchers want to know if those who receive the pass manage their HIV better and use
Who is the study for?
This trial is for people living with HIV who don't have stable housing. Participants should be willing to complete surveys and allow access to their HIV lab tests. There are no specific exclusion criteria provided, but typically participants would need to meet certain health standards.
What is being tested?
The study is testing whether giving out unlimited transit passes can help improve the management of HIV and increase the use of social services among unstably housed individuals. It compares a group with these passes against one without, over six months.
What are the potential side effects?
Since this trial involves providing transportation assistance rather than a medical intervention, there are no direct side effects from drugs or treatments. However, changes in lifestyle or stress levels due to increased mobility could indirectly affect participants.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot communicate in English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants with HIV Viral Suppression
Number of Participants with an HIV related Medical Visit
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
The intervention group will be provided a transit pass for the Minneapolis Metro transit system that will be paid for by the study for 6 months.
Group II: ControlActive Control1 Intervention
The control group will receive the current standard of care, in which people are eligible to receive up to two $10 bus cards from their case manager per month.
Find a Location
Who is running the clinical trial?
The Aliveness ProjectLead Sponsor
Jay Orne, PhDPrincipal InvestigatorThe Aliveness Project